Related Experiment Video
Updated: May 27, 2026

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
Published on: May 10, 2020
Hypomagnesemia and cardiovascular system
Insights
Magnesium depletion, often caused by diuretics, can lead to arrhythmias and sudden death. Early magnesium administration may prevent these events and benefit patients with myocardial infarction.
Area of Science:
- Cardiology
- Clinical Medicine
- Biochemistry
Background:
- Magnesium depletion is common in patients using loop diuretics and thiazides, affecting over one-third of them.
- Magnesium deficiency is linked to arrhythmias, sudden death, and atherosclerosis.
- This ion plays a role in myocardial damage following experimental coronary artery occlusion.
Purpose of the Study:
- To investigate the role of magnesium in preventing adverse cardiovascular events.
- To evaluate the impact of magnesium administration on myocardial infarction outcomes.
Main Methods:
- Review of clinical data on magnesium depletion and diuretic use.
- Analysis of experimental animal studies on magnesium deficiency and atherosclerosis.
- Examination of human studies on magnesium administration in myocardial infarction.
Main Results:
- Over one-third of patients on diuretics exhibit hypomagnesemia.
- Experimental evidence suggests magnesium deficiency promotes atherosclerotic lesions and myocardial damage.
- Early magnesium administration (within 24 hours) in myocardial infarction patients showed beneficial effects on first-year mortality.
Conclusions:
- Magnesium administration could potentially prevent arrhythmias and sudden death associated with depletion.
- Further clinical investigation is required to establish definitive conclusions on magnesium's role in cardiovascular health and myocardial infarction recovery.
Abstract:
Magnesium depletion in clinical practice is mainly related to loop diuretics and thiazides. Among patients treated with diuretics more than 1/3 exhibit hypomagnesa. Arrhythmias and sudden death attributed to magnesium depletion could be prevented by Mg administration. Magnesium deficiency in experimental animals promotes atherosclerotic lesions whereas this ion is involved in various stages of myocardial damage after experimental coronary artery occlusion. In humans magnesium administration in the first 24 hours of myocardial infarction was related to beneficial effects in first year mortality rate. Nevertheless more evidence from clinical investigation is needed for permanent conclutions.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Chronic Kidney Disease II: Clinical Manifestations
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Hemodialysis II: Procedure and Complications
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Skeleton and Calcium Homeostasis
